10,521
Total Claims
$2.0M
Drug Cost
1,179
Beneficiaries
$1,681
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+10%
Cost per patient vs peers
$1,681 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,474 claims · $164K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 735 | $757K |
| Rivaroxaban | 252 | $264K |
| Sacubitril/Valsartan | 220 | $241K |
| Empagliflozin | 202 | $236K |
| Evolocumab | 188 | $122K |
| Alirocumab | 40 | $34K |
| Evolocumab | 25 | $24K |
| Bempedoic Acid/Ezetimibe | 34 | $24K |
| Bempedoic Acid | 29 | $23K |
| Icosapent Ethyl | 41 | $19K |
| Ticagrelor | 31 | $17K |
| Metoprolol Succinate | 936 | $16K |
| Pitavastatin Calcium | 21 | $14K |
| Icosapent Ethyl | 30 | $13K |
| Dapagliflozin Propanediol | 13 | $12K |
Prescribing Profile
80
Unique Drugs
$1.5M
Patient Profile
73
Avg Age
57%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data